da Silva-Souza HA, de Lira MN, Patel NK, Spray DC, Persechini PM, Scemes E. Inhibitors of the 5-lipoxygenase pathway activate pannexin1 channels in macrophages via the thromboxane receptor. Am J Physiol Cell Physiol 307: C571-C579, 2014. First published July 30, 2014; doi:10.1152/ajpcell.00087.2014.-A multitude of environmental signaling molecules influence monocyte and macrophage innate and adaptive immune responses, including ATP and prostanoids. Interestingly, purinergic (P2) and eicosanoid receptor signaling interact such that the activation of P2 receptors leads to prostanoid production, which can then interfere with P2Y-mediated macrophage migration. Recent studies suggest that blockade of 5-lipoxygenase (5-LOX) in macrophages can activate a permeation pathway involved in the influx of dye and the release of ATP. Here, we provide evidence that pannexin1 (Panx1) is a component of this pathway and present the intracellular signaling molecules linking the thromboxane (TP) receptor to Panx1-mediated dye influx and ATP release. Using pharmacological tools and transgenic mice deficient in Panx1, we show that two 5-LOX pathway inhibitors induce ATP release and influx of dye in a Panx1-dependent manner. Electrophysiological recordings performed in wild-type and Panx1-deficient macrophages confirmed that these 5-LOX pathway inhibitors activate currents characteristic of Panx1 channels. We found that the mechanism by which Panx1 channels are activated under this condition involves activation of the TP receptor that is mediated by the cAMP/ PKA pathway. This is to our knowledge the first evidence for the involvement of Panx1 in the TP receptor signaling pathway. Future studies aimed to clarify the contribution of this TP-Panx1 signaling network to macrophage immune responses are likely to be important for targeting inflammatory and autoimmune diseases. ATP release; dye uptake; macrophages; pannexin; prostanoids PURINES/PYRIMIDINES AND EICOSANOIDS are important modulators of monocyte function, inducing the production and release of cytokines, migration, differentiation, and apoptosis. Interestingly, the nucleotide and eicosanoid signaling pathways interact. For instance, activation of P2 purinergic receptors in macrophages has been reported to lead to prostanoid production through the generation of arachidonic acid (AA) (7, 10, 24, 54) . On the other hand, prostaglandin E 2 (PGE 2 ) has been shown to interfere with P2Y-mediated macrophage migration by inhibiting Ca 2ϩ mobilization and AKT (v-Akt murine thymoma viral oncogene homolog) phosphorylation induced by P2Y receptors (53). Moreover, blockade of 5-LOX, the enzyme that transforms AA into leukotrienes (12, 37, 38, 57) , has been shown to decrease intracellular levels of ATP (2) and to attenuate ATP-induced macrophage cell death (7).
PURINES/PYRIMIDINES AND EICOSANOIDS are important modulators of monocyte function, inducing the production and release of cytokines, migration, differentiation, and apoptosis. Interestingly, the nucleotide and eicosanoid signaling pathways interact. For instance, activation of P2 purinergic receptors in macrophages has been reported to lead to prostanoid production through the generation of arachidonic acid (AA) (7, 10, 24, 54) . On the other hand, prostaglandin E 2 (PGE 2 ) has been shown to interfere with P2Y-mediated macrophage migration by inhibiting Ca 2ϩ mobilization and AKT (v-Akt murine thymoma viral oncogene homolog) phosphorylation induced by P2Y receptors (53) . Moreover, blockade of 5-LOX, the enzyme that transforms AA into leukotrienes (12, 37, 38, 57) , has been shown to decrease intracellular levels of ATP (2) and to attenuate ATP-induced macrophage cell death (7) .
ATP is well known to induce membrane permeabilization in macrophages through the activation of P2X 7 receptors and pannexin1 (Panx1) channels (20, 24) . Panx1, a member of the gap junction gene family, forms plasma membrane channels that are permeable to relatively large molecules (up to 1.5 kDa), including ATP (3).
Interestingly, it was recently found that 5-LOX inhibitors induced the influx of cationic dyes in macrophages independently of P2X 7 receptor activation (36, 46) and that such influx did not occur after inhibiting the activity of cyclooxygenases (COX-1 and COX-2), enzymes that transform AA into prostanoids (12, 37, 38, 57) . Thus these recent studies raise the possibility that the production of prostanoids resultant from the blockade of the 5-LOX pathway activates a permeation pathway with properties (influx of dye and ATP release) similar to those described for Panx1. Therefore, the present study was undertaken to identify and characterize the signaling pathway involved in macrophage dye and ATP permeabilities induced by blockers of the 5-LOX pathway. Using transgenic mice and pharmacological tools, we found that Panx1 is activated following the addition of 5-LOX inhibitors through a mechanism involving cAMP production due to thromboxane (TP) receptor activation. Moreover, our data showing that macrophages release ATP in response to 5-LOX inhibitors have important implications for the understanding of the interplay between purinergic and prostanoid signaling in the biology of monocytes.
MATERIAL AND METHODS

Materials
DMEM, fetal bovine serum, penicillin and streptomycin were obtained from Gibco 
were from Cayman Chemical. Thioglycolate medium was from Difco; phosphate-buffered saline (PBS), EGTA, NaCl, MgCl2, CaCl2, KCl, CsCl, nordihydroguaiaretic acid (NDGA), HEPES, dimethyl sulfoxide (DMSO), N6,2=-O-dibutyryladenosine 3=:5=-cyclic monophosphate sodium (db-cAMP), ␥,4-dihydroxy-2-(6-hydroxy-1-heptenyl)-4-cyclopentanecrotonic acid -lactone (brefeldin-A: BFA), 3␤-hydroxy-11-oxoolean-12-en-30-oic acid 3-hemisuccinate (carbenoxolone diso-dium salt: CBX), and firefly luciferase (EC 1.13.12.7) were purchased from Sigma-Aldrich; YO-PRO1 was from Life Technologies; N- [2-(methylamino) ethyl] isoquinoline-5-sulfonamide dihydrochloride (H-8.2HCl) was from Santa Cruz Biotechnology; Enliten ATP assay system was from Promega; BCA reagents were from Thermo Scientific; Superscript VILO cDNA Synthesis Kit and oligofectamine reagent were purchased from Invitrogen.
Most reagents were prepared as ϫ1,000 stock solutions either in DMSO (MK-886, NDGA, BFA, CBX, SQ29548, and YO-PRO1) or ethanol (I-BOP) or Milli-Q water (db-cAMP), and aliquots were kept frozen until use. NDGA was prepared fresh on the day of the experiment.
Animals
Male adult (2-4 mo old) wild-type and Panx1-deficient [Panx1 tm1a(KOMP) Wtsi] mice on the C57Bl/6 background were used in this study. Panx1-deficient mice originally purchased from KOMP (Knockout Mouse Project) were bred and maintained in the Institute for Animal Studies at Albert Einstein College of Medicine. As previously described (15) , these Panx1-deficient mice are hypomorph, not complete knockouts at the gene level; these mice are here referred as Panx1-hypo. All experiments were preapproved by the Institutional Animal Care and Use Committee.
Cell Cultures
Macrophage cultures. Macrophages were obtained from the intraperitoneal cavity of mice collected 4 days after thioglycolate injection, as previously described (8) . In brief, cells collected in PBS were plated for 1 h on glass-bottomed dishes (MatTek), on coverslips, or in 24-well plates containing DMEM, supplemented with 10% FCS and 1% of penicillin/streptomycin at 37°C in an incubator with humidified atmosphere containing 5% CO 2. Nonadherent cells were washed out and the macrophage cultures maintained for at least 2 days before experimentation. All experiments were performed at room temperature (RT).
J774 mouse macrophage cell line. Parental and Panx1-deficient J774 cells were obtained and maintained as previously described (20) . Briefly, J774 cells were cultured in 60-mm dishes containing DMEM, supplemented with 10% FCS, and 1% penicillin/streptomycin and maintained in a humidified chamber with 5% CO 2 at 37°C. Before experimentation, cells were trypsinized and transferred to glassbottomed dishes.
Dye influx
The influx of the dye YO-PRO1 (Invitrogen) was performed as previously described (19, 52) . Briefly, J774 (parental and Panx1 deficient) and peritoneal macrophages (WT and Panx1-hypo) plated on glass-bottomed dishes were bathed in a basal salt solution (BSS in mM: 145 NaCl, 5 KCl, 1 MgCl 2, 1 CaCl2, and 10 Na-HEPES, pH 7.4) containing the cell-impermeant dye YO-PRO1 (5 M). After a 5-min measurement of basal fluorescence intensity, cells were exposed to the 5-LOX inhibitor NDGA (50 M), the thromboxane mimetic I-BOP (50 M), or to db-cAMP (500 M) and fluorescence intensity was measured for 10 min. For blocking experiments, cells were preincubated for 30 min with the TP receptor antagonist SQ29548 (10 M) or the PKA inhibitor H-8 (50 M), before the addition of NDGA, I-BOP, or db-cAMP. All compounds were dissolved in BSS containing YO-PRO1 (5 M), and experiments were performed at RT. YO-PRO1 fluorescence intensity obtained from regions of interest placed randomly on cells was captured using an Orca-ER chargecoupled device camera (Hamamatsu) attached to an inverted microscope (Eclipse 2000; Nikon), equipped with a ϫ20 dry objective and 488/512 nm excitation/emission filter set and Metafluor software version 7.1 (Molecular Devices). Dye influx was reported as the ratio of YO-PRO1 fluorescence intensity normalized to basal values (F/F 0).
Electrophysiology
Whole cell voltage-clamp recordings were performed at RT on WT and Panx1-hypo peritoneal macrophages plated on coverslips and bathed in BSS (see above). Heat-polished micropipettes (5-10 M⍀) were filled with internal solution (in mM: 130 CsCl, 10 EGTA, 10 HEPES, and 0.5 CaCl 2). Cell membrane potential was held at Ϫ60 mV after forming high-resistance seals (1-10 G⍀), and current amplitudes were evaluated using a ramp (Ϫ60 to ϩ80 mV, 5-s duration, 20 trials) followed by step pulse (Ϫ60 to ϩ140 mV, 10-mV steps, 800-ms duration) protocols. Cells were stimulated with NDGA (5 M), MK-886 (5 M), I-BOP (5-50 M), and db-cAMP (50 M), and a voltage-ramp protocol was repeatedly applied until maximal current amplitude was attained (4 min: NDGA, MK-886, I-BOP; 10 min: db-cAMP). Current amplitudes were then measured from voltage-step pulses. For experiments using blockers, cells were incubated for 30 min with SQ29548 (10 M) or H-8 (50 M) before the addition of the tested compounds. Data were acquired with an Axopatch-1C amplifier and digitized using an Axon Instruments Digitizer (Molecular Devices). Clampex and Clampfit software (version 10.2) were used for recording and analysis, respectively.
Measurements of ATP
The amount of ATP released from WT and Panx1-hypo peritoneal macrophages was measured as previously described (50, 51) . Cells plated in 24-well plates were washed twice with BSS (in mM: 145 NaCl, 5 KCl, 1 MgCl 2, 1 CaCl2, and 10 Na-HEPES, pH 7.4). Cells were then incubated for 1 min at RT with 50 M NDGA or I-BOP in the absence or presence (30-min preincubation) of CBX (50 M), BFA (10 M), SQ-29548 (10 M), and H-8 (50 M). Aliquots of bathing solutions were collected before and after cell stimulation and kept at Ϫ20°C until analysis that was performed using the luciferin/ luciferase assay (Enliten ATP Assay System; Promega) and a Turner luminometer. The concentrations of ATP released from cells were obtained from standard curves and normalized to the total amount of protein measured using the BCA reagents (Thermo Scientific).
Quantitative RT-PCR
WT and Panx1-hypo peritoneal macrophages were used to quantify the levels of Panx1 transcripts, as previously described (15) . Total RNA was extracted using the plus mini kits (Qiagen) according to the manufacturer's protocol. Complementary DNA was synthesized from 1 g/10 l of RNA, using a Superscript VILO cDNA Synthesis Kit (Invitrogen). Primers used were Panx1 (F: AGCCAGAGAGTG-GAGTTCAAAGA; R: CATTAGCAGGACGGATTCAGAA) and 18S ribosomal RNA (F: CACGGCCGGTACAGTGAAAC; R: AGAGG-AGCGAGCGACCAAA). 18S was used as housekeeping gene for normalization. Real-time RT-PCR was performed using SYBR Green PCR Master Mix with 7300 Fast Real-Time PCR system (Applied Biosystems). Reaction mixtures were denatured at 95°C for 10 min, followed by 40 PCR cycles. Each cycle consisted of the following three steps: 94°C for 15 s, 57°C for 15 s, and 72°C for 1 min. Each sample was normalized against internal controls (18S ribosomal); the relative values for target abundance were extrapolated from standard curves generated from the reference standard.
Data Analysis
Statistical significance was determined using ANOVA followed by Newman-Keuls multiple comparison test or unpaired t-test. A P value Ͻ0.05 was considered significant. Numbers of animals used are indicated in parentheses.
RESULTS
Membrane Permeabilization Induced by Inhibitors of the 5-LOX Pathway Involves Panx1 Channels
Recently, it was reported that blockers of the 5-LOX pathway resulted in the uptake of fluorescent molecules in macrophage through an unknown, P2X 7 receptor-independent mechanism (36, 46) . The possible involvement of Panx1 in the phenomenon of NDGA-induced membrane permeabilization was here investigated using the J774 macrophage cell line and peritoneal macrophages in which Panx1 expression was manipulated by shRNA knockdown and transgenesis, respectively. As shown in Fig. 1, A and B, no influx of YO-PRO1 was recorded from cells deficient in Panx1 when stimulated with NDGA (50 M). Further confirmation that NDGA activates Panx1 channels was obtained by means of electrophysiological recordings on peritoneal macrophages derived from WT and Panx1-hypo mice (Fig. 1, C-F) . Bath application of 5 M NDGA to macrophages induced a time-dependent increase in outward currents that stabilized around 4 min after drug application (Fig. 1C) . Four minutes after NDGA application, the conductance measured at ϩ80 mV doubled, increasing from 1.64 Ϯ 0.06 nS at control condition to 3.40 Ϯ 0.03 nS (Fig. 1C,  inset) . After this stabilization period, cells were subjected to a voltage-step protocol (Fig. 1D ) and the amplitudes of NDGAinduced currents were measured in WT and Panx1-hypo macrophages. As shown in Fig. 1E, 4 min after NDGA application, current amplitudes recorded from WT macrophages were significantly larger compared with untreated cells, while in Panx1-hypo macrophages, NDGA did not induce changes in currents. The Panx1 channel blocker CBX (5 M) prevented the NDGA-induced 1.8-fold increase in outward currents in WT macrophages (control: 183.8 Ϯ 51.2 pA; NDGA: 328.3 Ϯ 97.8 pA; CBX ϩ NDGA: 184.8 Ϯ 48.1 pA; nϭ 3). Similar results were obtained when using the more specific 5-LOX inhibitor MK-886 (Fig. 1F) . At 5 M, MK-886 induced outward currents (388.4 Ϯ 52.9 pA; n ϭ 3) with amplitudes similar to those generated by 5 M NDGA (461.2 Ϯ 30.3 pA; n ϭ 4); no changes in current amplitudes were recorded from Panx1-hypo macrophages exposed to MK-886 (Fig. 1F) . 
Inhibitors of the 5-LOX Pathway Induce ATP Release from Peritoneal Macrophages
Previous studies indicated that inhibitors of the 5-LOX pathway reduced intracellular levels of ATP and caused the release of cytosolic ATP from peritoneal macrophages (2, 46).
To gain insight into the mechanisms involved in ATP release, C57Bl/6 peritoneal macrophages were treated for 30 min with the Panx1 channel blocker CBX (50 M) or with the vesicular transport blocker BFA (10 M) before NDGA (50 M) application. As shown in Fig. 2A above, CBX and BFA significantly , respectively. Although reduced, the latter values were significantly higher than the amount of ATP released under control, untreated condition (0.49 Ϯ 0.10 nM·g Ϫ1 ·l protein Ϫ1 ). Coapplication of CBX and BFA reduced the amount of ATP released by NDGA to levels (0.71 Ϯ 0.09 nM·g Ϫ1 ·l protein Ϫ1 ) that were not significantly different from control, untreated conditions. As a further test for the participation of Panx1 in response to NDGA application, we used peritoneal macrophages derived from Panx1-deficient mice. As expected from the CBX experiments, the release of ATP induced by NDGA was prevented in Panx1-hypo mice (Fig. 2, B and C) . Together, these data suggest that ATP release involves two pathways, one being vesicular and the other through ion channels mainly formed by Panx1.
Activation of Panx1 via TP Receptors
Given that our results showed that NDGA and MK-886 affected Panx1 channels in a similar way, we speculated that their effects could be mediated by AA metabolites other than leukotrienes, in particular those derived from COX activity, such as thromboxane (Fig. 3A above) . To test this possibility, we assessed Panx1 activity by measuring the amount of ATP release and influx of YO-PRO1, as well as the amplitudes of Panx1 currents in WT and Panx1-hypo macrophages treated with TP receptor agonist and antagonist (Fig. 3) . As indicated in Fig. 3B , NDGA-induced ATP release was prevented by a 30-min preincubation with 10 M of the TP receptor antagonist SQ-29548. SQ-29548 also prevented ATP release induced by the TP receptor agonist I-BOP (50 M). The influx of YO-PRO1 induced by NDGA (1.19 Ϯ 0.02; n ϭ 10) and I-BOP (1.25 Ϯ 0.04; n ϭ 3) was significantly reduced to 0.97 Ϯ 0.01 and 1.11 Ϯ 0.02, respectively, when WT macrophages were pretreated with the TP receptor antagonist (Fig. 3C) . No influx of dye was recorded from Panx1-hypo macrophages treated with NDGA or I-BOP (Fig. 3C) . Electrophysiological recordings provided further support for the involvement of TP receptor in Panx1 channel activation following 5-LOX inhibition. Panx1 current amplitudes were significantly increased when cells were stimulated with I-BOP (Ն10 M; Fig. 3D ). The fold increase in Panx1 currents induced by I-BOP (1.46 Ϯ 0.07; n ϭ 3) was not significantly different from that induced by MK-866 (1.63 Ϯ 0.22; n ϭ 3) and by NDGA (1.56 Ϯ 0.10; n ϭ 4; P Ͼ 0.05 ANOVA; compare Fig. 3D and 2E ). The TP receptor antagonist SQ-29548 totally prevented Panx1 currents induced by NDGA, MK-886, and I-BOP (Fig. 3E) . Because percent inhibition was estimated relative to control values (before the addition of NDGA), inhibition by Ͼ100% likely represents the presence of variable numbers of active Panx1 channels under control conditions. Together, these results indicate that the mechanism linking the blockade of the 5-LOX pathway by NDGA and MK-886 to the activation of Panx1 channels involves the production of prostanoids, one candidate being thromboxane A2 (TXA2) acting on TP receptors.
cAMP/PKA Pathway Mediates Panx1 Activation
To gain insight into the possible intracellular signaling cascades involved in the activation of Panx1 via TP receptor stimulation, we evaluated whether cAMP and PKA were involved. This hypothesis was explored because macrophages have been reported to express a TP receptor that is linked to adenylyl cyclase-G s -coupled protein (28, 29, 48) . As shown in Fig. 4, A and B above, db-cAMP (50 M) significantly increased Panx1 currents (1.46 Ϯ 0.11 fold; n ϭ 4) and YO-PRO1 uptake (1.17 Ϯ 0.11 fold; n ϭ 4) in WT but not in Panx1-hypo macrophages. To test for the participation of PKA in the activation of Panx1 mediated by TP receptors, we pretreated the cells with the PKA inhibitor H-8 before the addition of NDGA. We used the 5-LOX inhibitor instead of the TP receptor agonist (I-BOP) to further test the hypothesis linking prostanoid production following 5-LOX inhibition and Panx1 activation via the TP receptor. As expected, the PKA inhibitor H-8 prevented NDGA-induced YO-PRO1 uptake, ATP release, and the augmentation of Panx1 currents (Fig. 4, D-F) . Thus these data support the hypothesis that activation of Panx1 channels in response to NDGA application involves the cAMP/ PKA signaling cascade resultant from TP receptor stimulation, as illustrated in Fig. 5 .
DISCUSSION
Monocytes and macrophages play a central role in complex innate and adaptive immune responses, and their functions are influenced by a multitude of environmental signaling molecules, including ATP and prostanoids (2, 7, 13, 53) . It is becoming apparent that prostanoid and purinergic receptor signaling networks interact to modulate macrophage immune responses. For instance, large amounts of prostanoids are produced by macrophages in response to ATP stimulation; released prostanoids then act in an autocrine/paracrine fashion to regulate immune responses (1, 9, 23 ). On the other hand, interference with the eicosanoid biosynthesis pathway, as in the case of compounds that block the 5-LOX, has been shown to prevent P2X 7 receptor-mediated apoptosis and to decrease cytosolic ATP levels (2, 7) .
Interestingly, inhibitors of the 5-LOX pathway were reported to induce membrane permeabilization and ATP release from macrophages through a yet not identified mechanism (36, 46) . We here show for the first time that Panx1 channels are activated following the blockade of 5-LOX pathway and that these channels are involved, at least in part, in the release of ATP and influx of dyes. The intracellular signaling pathways leading to Panx1 activation likely involve a PKA-mediated posttranslational modification resulting from the production of cAMP following activation of TXA2 (TP) receptors. The COOH terminus of Panx1 has one threonine and six serine consensus sites for phosphorylation (35) ; Panx1 phosphorylation increases upon contraction of skeletal muscles (41) . However, there is no report demonstrating that a particular kinase (PKC, PKA) phosphorylates Panx1 at specific residues. Further studies are necessary to evaluate whether or not PKA directly phosphorylates Panx1 channels leading to its opening as reported here.
Our data showing that blockade of 5-LOX pathway by NDGA-and MK886-induced influx of dye and ATP release in a Panx1-dependent manner are corroborated by our results showing that these inhibitors induced outward currents in WT but not in Panx1-deficient peritoneal macrophages. Although Panx1 channel seems to provide a conduit for YO-PRO1 uptake following 5-LOX pathway blockade, additional mechanisms for the release of ATP from macrophages are likely to be in place. For instance, LPS-treated monocytes and NDGA/ MK-866 treated macrophages release ATP mainly via exocytosis (11, 42, 46) . In contrast, it has been recently shown that lipoxin-A4, a nonclassical eicosanoid, induces ATP release from airway epithelial cells mainly via Panx1 channels with a minor contribution of secretory vesicles (16) . Our present study showing that the Panx1 channel blocker (CBX) and the vesicular transporter blocker (BFA) partially reduced the amount of ATP released and that coapplication of both blockers produced additive effects ( Fig. 2A) indicates that two distinct and parallel pathways are involved in the NDGAinduced ATP release from macrophages. Although future studies are required to elucidate the relative contribution of each of these two pathways to macrophage immune responses, we investigated here the mechanism by which Panx1 is activated following blockade of 5-LOX pathway.
Panx1 channels are known to be activated basically by two means, via an intracellular signaling cascade and by the direct action of the stimulant on the channel itself. In the first case, activation of membrane (P2 and N-methyl-D-aspartate) receptors opens Panx1 channels through a mechanism involving elevation of intracellular Ca 2ϩ (25) and/or Src-tyrosine kinase (20, 55) . The alternative mode of Panx1 channel activation involves the direct action of a "stimulant" on the channel itself, as is the case of elevated extracellular K ϩ , which binds to one of the extracellular loops of the protein (21, 47) .
Inspection of Panx1 current development following NDGA or MK-886 application revealed that a moderately long time course is necessary for the full development of Panx1 currents (ϳ4 min); this suggests that the action of the drugs is not directly on the channel, as would be expected from off-target effects reported for many 5-LOX inhibitors (27) but likely involves AA intermediate molecules, such as those generated by COX activity. The possibility that blockade of LOX activity could lead to a metabolic shunt in a similar but opposite direction than the arachidonate metabolic shunt reported to occur from COX to LOX (24, 26) is supported by our data showing that TP receptor stimulation leads to Panx1 channel activation. In this regard, we found that blockade of the TP receptor with SQ29458 prevents NDGA-induced dye influx, ATP release, and Panx1 currents. Further support for the hypothesis that blockade of 5-LOX shunts AA metabolites towards the generation of prostanoids are our data showing that the TXA2 mimetic I-BOP had similar effects to those produced by NDGA and MK-866.
Although direct measurements of TXA2 levels generated following the blockade of 5-LOX are necessary, our proposed model for the synthesis of TXA2 in the absence of increased PLA2-mediated AA production is based on reports indicating that thromboxane synthase is abundantly expressed in activated macrophages [see Tone et al. (52) ] and that these cells, differently from resting macrophages, convert AA mainly into TXA2, which is released faster than PGE 2 (4, 30) .
Thus our data indicate that activation of Panx1 following the blockade of the 5-LOX pathway is likely mediated by TXA2 acting on the G protein-coupled TP receptor. Differently from humans where TP receptors consist of two isoforms (TP␣ and TP␤: 17, 18, 40), mice express only one isoform that is 76% identical to the human TP␣ (31, 33) . As would be expected from a TP␣ isoform that elevates cytosolic levels of cAMP (17), we show that Panx1 channels in peritoneal macrophages can be activated by db-cAMP and that blockade of the cAMPdependent protein kinase (PKA) prevents NDGA-induced Panx1 currents, dye influx, and ATP release.
Interestingly, however, the effects db-cAMP on Panx1 channels were less pronounced than those induced by I-BOP, suggesting the requirement of additional inputs from prostacyclin receptors and/or from the TP receptor itself but via G q /PLC signaling pathway. The involvement of G q signaling arm of TP receptors seems unlikely given that NDGA-induced membrane permeabilization in peritoneal macrophages is independent of intracellular calcium levels (46) . It remains possible that the heterodimerization of prostacyclin receptors and TP receptors is necessary to enhance cAMP levels in response to TP␣ stimulation, as shown for human TP receptors (56) .
Prostanoids and their receptors control several cellular processes, including acute inflammation and innate and adaptive immunity. They thus represent a complex system of immunoregulation, with varied and distinct outcomes dependent on receptor types and subtypes. Although monocytes/macrophages are enriched in thromboxane synthase and release large amounts of TXA2 upon stimulation (6, 30, 32, 52) , the function of TXA2-TP receptor signaling is not as well defined as it is the case for other immune cells. For instance, dendritic and T-cell interactions are inhibited by TXA2, and therefore, TXA2 negatively modulates acquired immunity (22) . Nevertheless, it is possible that by activating Panx1 channels TXA2-TP receptor signaling contributes positively to macrophage immune responses.
Several lines of evidence support the notion that Panx1 is a key component of immune responses. Panx1 is ubiquitously expressed and forms plasma membrane channels permeable to large molecules (reviewed in Refs. 5, 44, 45, 49) . Not only does Panx1 provide sites for the release of ATP (3, 19, 39, 51) , an important immune modulator, but it is also a component of the inflammasome leading to caspase-1 activation and the processing of IL-1␤ (34, 47) . Moreover, a recent study proposed pannexin/innexin as being the gatekeepers of microglia response to injury by showing that the dose-dependent inhibition of AA was correlated with pannexin/innexin activity and microglia migration towards the site of lesion (43) . In this situation, blockade of Panx1 channels by high levels of AA would prevent inflammasome activation, while lower levels of AA due to enzymatic catabolism would overcome the inhibition of Panx1 channels and promote an inflammatory response (43) .
Many processes involved in immune responses are regulated by a cross talk between different intracellular signaling networks including the prostanoid (TP), Toll-like (TL), purinergic (P2), and cytokine receptors. Here we provide the first evidence for the involvement of Panx1 in the TP receptor signaling network. Future studies aimed at clarifying the contribution of this TP-Panx1 signaling network to macrophage immune responses are likely to be important for targeting inflammatory and autoimmune diseases.
